[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health":3,"$f2nb5rw1su706e":14},{"ok":4,"db":5,"lastOrangeBookRun":6,"lastDrugsFdaRun":9,"lastAlertsRun":12,"stale":13},true,"ok",{"status":5,"startedAt":7,"finishedAt":8,"lastOkAt":8},"2026-10-26T06:44:32.239Z","2026-10-26T06:44:53.640Z",{"status":5,"startedAt":10,"finishedAt":11,"lastOkAt":11},"2026-10-26T06:45:02.648Z","2026-10-26T06:45:13.189Z",null,false,{"tradeName":15,"ingredient":16,"applicant":17,"applicantSlug":18,"applNos":19,"loe":12,"latestLoe":12,"basis":22,"carveOutPossible":13,"openStrengths":23,"headlineStrengths":23,"headlineFallback":13,"approvalsBeforeLoe":24,"products":25,"patents":41,"exclusivities":42,"paragraphIv":43,"catalysts":45},"MEPRON","ATOVAQUONE","GLAXOSMITHKLINE LLC","glaxosmithkline-llc",[20,21],"020259","020500","none",1,0,[26,34],{"key":27,"applNo":20,"productNo":28,"dosageForm":29,"route":30,"strength":31,"approvalDate":32,"rld":4,"teCode":12,"type":33,"loe":12,"basis":22,"carveOutPossible":13},"020259-001","001","TABLET","ORAL","250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**","1992-11-25","DISCN",{"key":35,"applNo":21,"productNo":28,"dosageForm":36,"route":30,"strength":37,"approvalDate":38,"rld":4,"teCode":39,"type":40,"loe":12,"basis":22,"carveOutPossible":13},"020500-001","SUSPENSION","750MG\u002F5ML","1995-02-08","AB","RX",[],[],{"asOf":12,"firstFiled":12,"entries":44},[],[]]